Impaired absorption of insulin aspart from lipohypertrophic injection sites.
Johansson
Unn-Britt
UB
Sophiahemmet University College, Box 5605, SE-114 86 Stockholm, Sweden. unn-britt.johansson@sophiahemmethogskola.se
Amsberg
Susanne
S
Hannerz
Lena
L
Wredling
Regina
R
Adamson
Ulf
U
Arnqvist
Hans J
HJ
Lins
Per-Eric
PE
D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000378:metabolism; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D007279:Injections, Subcutaneous / Q000009:adverse effects*; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D061267:Insulin Aspart; D008060:Lipodystrophy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D012869:Skin Absorption
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D061267:Insulin Aspart